These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8906076)

  • 1. Chemiluminescence immunoassay for vascular endothelial growth factor (vascular permeability factor) in tumor-tissue homogenates.
    Schlaeppi JM; Eppenberger U; Martiny-Baron G; Küng W
    Clin Chem; 1996 Nov; 42(11):1777-84. PubMed ID: 8906076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts.
    Span PN; Grebenchtchikov N; Geurts-Moespot J; Westphal JR; Lucassen AM; Sweep CG
    Int J Biol Markers; 2000; 15(2):184-91. PubMed ID: 10883894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; Boonstra H; Sweep CG
    Cancer; 2001 Jan; 91(2):371-7. PubMed ID: 11180084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
    Linderholm B; Grankvist K; Wilking N; Johansson M; Tavelin B; Henriksson R
    J Clin Oncol; 2000 Apr; 18(7):1423-31. PubMed ID: 10735889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.
    Turley H; Scott PA; Watts VM; Bicknell R; Harris AL; Gatter KC
    J Pathol; 1998 Nov; 186(3):313-8. PubMed ID: 10211122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of vascular endothelial growth factor (VEGF)/soluble VEGF receptor-1 relationship in breast cancer.
    Toi M; Bando H; Ogawa T; Muta M; Hornig C; Weich HA
    Int J Cancer; 2002 Mar; 98(1):14-8. PubMed ID: 11857378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor in normal and tumour oral tissues assessed with different antibodies.
    Baillie R; Harada K; Carlile J; Macluskey M; Schor SL; Schor AM
    Histochem J; 2001 May; 33(5):287-94. PubMed ID: 11563542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly elevated levels of vascular endothelial growth factor in malignant ascites.
    Zebrowski BK; Liu W; Ramirez K; Akagi Y; Mills GB; Ellis LM
    Ann Surg Oncol; 1999 Jun; 6(4):373-8. PubMed ID: 10379858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prognostic value of vascular endothelial growth factor in breast cancer].
    Jing J; Zhao Y; Li H; Zhang S; Shi Z
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):566-8. PubMed ID: 12528550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas.
    Hartenbach EM; Olson TA; Goswitz JJ; Mohanraj D; Twiggs LB; Carson LF; Ramakrishnan S
    Cancer Lett; 1997 Dec; 121(2):169-75. PubMed ID: 9570355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive fluorometric enzyme-linked immunosorbent assay that measures vascular endothelial growth factor165 in human plasma.
    Rodriguez CR; Fei DT; Keyt B; Baly DL
    J Immunol Methods; 1998 Oct; 219(1-2):45-55. PubMed ID: 9831387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor.
    Asano M; Yukita A; Suzuki H
    Jpn J Cancer Res; 1999 Jan; 90(1):93-100. PubMed ID: 10076571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival.
    Obermair A; Kucera E; Mayerhofer K; Speiser P; Seifert M; Czerwenka K; Kaider A; Leodolter S; Kainz C; Zeillinger R
    Int J Cancer; 1997 Aug; 74(4):455-8. PubMed ID: 9291439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large amounts of vascular endothelial growth factor at the site of hemostatic plug formation in vivo.
    Weltermann A; Wolzt M; Petersmann K; Czerni C; Graselli U; Lechner K; Kyrle PA
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1757-60. PubMed ID: 10397695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
    Linderholm B; Tavelin B; Grankvist K; Henriksson R
    Br J Cancer; 1999 Oct; 81(4):727-32. PubMed ID: 10574263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
    Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
    Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.